Meissa Vaccines is a pharmaceutical company focused on the advancement of unmet vaccines against viruses that cause serious human diseases, such as respiratory syncytial virus, respiratory medical need in pediatrics, and rhinovirus. The company employs synthetic biology and reverses genetics to recode specific RSV genes using targeted human codon deoptimization.
|HQ||South San Francisco, US||Map|
|Employees (est.) (Nov 2020)||16||(+15%)|
Meissa Vaccines total Funding
Meissa Vaccines latest funding size
Time since last funding
|a year ago|
Meissa Vaccines investors
|Morningside Technology Ventures|
Meissa Vaccines has 106 Twitter Followers. The number of followers has increased 3.3% month over month and increased 5.8% quarter over quarter
When was Meissa Vaccines founded?
Meissa Vaccines was founded in 2014.
Who are Meissa Vaccines key executives?
Meissa Vaccines's key executives are Karen Slobod, Roderick Tang and Fiona Cameron.
How many employees does Meissa Vaccines have?
Meissa Vaccines has 16 employees.
Who are Meissa Vaccines competitors?
Competitors of Meissa Vaccines include Xenikos, Allakos and CinCor Pharma.
Where is Meissa Vaccines headquarters?
Meissa Vaccines headquarters is located at 329 Oyster Point Blvd 3rd Floor, South San Francisco.
Where are Meissa Vaccines offices?
Meissa Vaccines has an office in South San Francisco.
How many offices does Meissa Vaccines have?
Meissa Vaccines has 1 office.
Receive alerts for 300+ data fields across thousands of companies